health ๐ฌ New treatment gives hope for advanced gastric cancer
A 65-year-old patient with HER2-positive metastatic gastric adenocarcinoma achieved long-term survival. This breakthrough happened through a personalized approach involving targeted therapy, radiotherapy, and surgery. The patient started showing severe symptoms in 2018 and responded well to CAPOX chemotherapy and trastuzumab. This combination allowed for tumor reduction and eventual conversion surgery to remove the stomach tumor. Targeted local therapies have successfully managed later recurrences, keeping the HER2-targeted therapy going.